About Jonathan Leff
Form D filings for Dracen Pharmaceuticals from 2018 to 2023 list Jonathan Leff as director.
Jonathan Leff first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Leff in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Leff works with at each company, as listed on that company's latest Form D.
Dracen Pharmaceuticals, Inc. · Form D, Aug 10, 2023
AR
Asher Rubin
Executive officer
DD
Drew Pardoll, M.D., Ph.D.
Director
DB
Dennis Bilski
Acting Chief Financial Officer